Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

801
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
801

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive Control in Pediatric Cancer Survivors: A task-fMRI study.

bioRxiv : the preprint server for biology·2026
Same author

Distinct Hippocampal Cellular Pathologies Influence Cognition Across Diagnostic Categories, Also Distinguishing Schizophrenia from Affective Psychoses.

bioRxiv : the preprint server for biology·2026
Same author

Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders.

JAMA network open·2026
Same author

Impaired Hippocampal Circuitry and Memory Dysfunction in Schizophrenia.

Nature. Mental health·2026
Same author

Amygdala microstructural changes in subjective cognitive decline: A diffusion kurtosis and neurite orientation dispersion and density imaging study.

Journal of Alzheimer's disease : JAD·2026
Same author

High prevalence of CNS-directed autoantibodies in patients with schizophrenia.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Aug 6, 2025

3D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse
15:26

3D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse

Published on: May 19, 2015

14.2K

Microstructural and Microvascular Alterations in Psychotic Spectrum Disorders: A Three-Compartment Intravoxel

Faye McKenna1,2, Pradeep Kumar Gupta1, Yu Veronica Sui1,2

  • 1Center for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, NY, USA.

Schizophrenia Bulletin
|March 15, 2023
PubMed
Summary

New imaging techniques reveal microvascular and microstructural changes in psychotic spectrum disorders (PSDs). These changes correlate with cognitive deficits and disease duration, offering potential biomarkers for PSD.

Keywords:
diffusion MRIfree watergray matterinflammationmagnetic resonance spectroscopy imagingmemoryperfusionwhite matter

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.3K

Related Experiment Videos

Last Updated: Aug 6, 2025

3D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse
15:26

3D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse

Published on: May 19, 2015

14.2K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

6.7K
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.3K

Area of Science:

  • Neuroimaging
  • Psychiatry
  • Vascular Biology

Background:

  • Microvascular and inflammatory processes are hypothesized contributors to psychotic spectrum disorders (PSDs).
  • Empirical data supporting these pathophysiological mechanisms in PSDs are limited.

Purpose of the Study:

  • To investigate microvascular and microstructural alterations in gray and white matter in individuals with PSDs.
  • To explore the relationship between these imaging metrics, cognitive function, and disease progression.

Main Methods:

  • Utilized a three-compartment intravoxel incoherent motion free water imaging (IVIM-FWI) technique.
  • Quantified perfusion fraction (PF), free water fraction (FW), and anisotropic diffusion (FAt) in gray and white matter.
  • Compared metrics between 55 young adults with PSD and 37 healthy controls (HCs).

Main Results:

  • Significantly increased PF, FW, and FAt in gray matter of PSD group compared to HCs.
  • Significantly increased PF and FW, with decreased FAt, in white matter of PSD group.
  • In patients, IVIM-FWI metrics correlated with cognitive test performance (memory, processing speed) and duration of psychosis.
  • Associations found between IVIM-FWI metrics and specific metabolites in the posterior cingulate cortex.

Conclusions:

  • The three-compartment IVIM-FWI model yields metrics sensitive to microvascular and microstructural changes in PSDs.
  • These metrics are associated with cognitive impairments and may serve as biomarkers for disease progression.